Dr. George on Critical Clinical Trials in Kidney Cancer
Daniel J. George, MD, associate professor of medicine, and surgery, director of GU Oncology at the Duke Cancer Institute, discusses critical phase III clinical trials in metastatic renal cell carcinoma (mRCC).